NeoGenomics (NEO) EV/EBITDA: History & Chart

NeoGenomics, Inc.(NEO)

Medical - Diagnostics & Research · Fort Myers, FL

$18.31+0.52 (+2.95%)

Delayed quote: Oct 2, 2026, 3:05 PM EDT

About NeoGenomics, Inc.

NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers. NeoGenomics' advanced testing capabilities encompass cytogenetics, which examines normal and abnormal chromosomes in relation to disease; fluorescence in-situ hybridization (FISH) for detecting and pinpointing specific DNA sequences and genes on chromosomes; and flow cytometry, used to measure cell population characteristics. Additionally, the company provides immunohistochemistry and digital imaging services, enabling the localization of cellular proteins in tissue sections, visualization of scanned slides, and quantitative analysis. Molecular testing, focusing on DNA/RNA analysis and gene structure/function, is also a key offering, alongside morphologic analysis where pathologists microscopically diagnose cells. Beyond clinical diagnostics, NeoGenomics supports pharmaceutical clients' oncology programs from discovery to commercialization and acts as a reference laboratory for anatomic pathology testing. The company, founded in 2001 and headquartered in Fort Myers, Florida, also maintains a strategic alliance and laboratory services agreement with Inivata Limited.

Fort Myers, FL

2,500 employees

www.neogenomics.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Anthony Zook

View full financials

NEO EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

68.24x

EV/EBITDA RATIO AVG 3Y

37.71x

EV/EBITDA RATIO AVG 5Y

22.68x

EV/EBITDA RATIO AVG 10Y

10.15x

EV/EBITDA RATIO AVG 15Y

13.02x

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
NeoGenomics, Inc. (NEO)	$470.35M	N/A	68.24x	37.71x	22.68x
NRC Health (NRC)vs ›	$459.30M	23.37x	16.26x	15.04x	16.68x
Shoulder Innovations, Inc. (SI)vs ›	$389.98M	N/A	N/A	N/A	N/A
PDS Biotechnology Corporation (PDSB)vs ›	$41.24M	N/A	N/A	N/A	N/A
Teladoc Health, Inc. (TDOC)vs ›	$1.01B	12.47x	29.31x	194.51x	194.51x
Intellia Therapeutics, Inc. (NTLA)vs ›	$1.71B	N/A	N/A	N/A	N/A
DENTSPLY SIRONA Inc. (XRAY)vs ›	$1.74B	4.46x	6.97x	36.61x	27.69x
Recursion Pharmaceuticals, Inc. (RXRX)vs ›	$2.13B	N/A	N/A	N/A	N/A
Beam Therapeutics Inc. (BEAM)vs ›	$2.49B	N/A	N/A	N/A	N/A
TransMedics Group, Inc. (TMDX)vs ›	$2.72B	26.38x	36.07x	85.76x	85.76x

NAME

MARKET CAP

EV/EBITDA RATIO

TTM

NeoGenomics, Inc. (NEO)

$470.35M

N/A

68.24x

37.71x

22.68x

NRC Health (NRC)vs ›

$459.30M

23.37x

16.26x

15.04x

16.68x

Shoulder Innovations, Inc. (SI)vs ›

$389.98M

N/A

PDS Biotechnology Corporation (PDSB)vs ›

$41.24M

N/A

Teladoc Health, Inc. (TDOC)vs ›

$1.01B

12.47x

29.31x

194.51x

Intellia Therapeutics, Inc. (NTLA)vs ›

$1.71B

N/A

DENTSPLY SIRONA Inc. (XRAY)vs ›

$1.74B

4.46x

6.97x

36.61x

27.69x

Recursion Pharmaceuticals, Inc. (RXRX)vs ›

$2.13B

N/A

Beam Therapeutics Inc. (BEAM)vs ›

$2.49B

N/A

TransMedics Group, Inc. (TMDX)vs ›

$2.72B

26.38x

36.07x

85.76x

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for NeoGenomics, Inc. (NEO)?

The EV/EBITDA ratio for NEO stock is N/A.

What is the estimated TTM average EV/EBITDA ratio for NeoGenomics, Inc. (NEO)?

The estimated TTM average EV/EBITDA ratio for NEO stock is 68.24x.

What is the estimated 3Y average EV/EBITDA ratio for NeoGenomics, Inc. (NEO)?

The estimated 3Y average EV/EBITDA ratio for NEO stock is 37.71x.

What is the estimated 5Y average EV/EBITDA ratio for NeoGenomics, Inc. (NEO)?

The estimated 5Y average EV/EBITDA ratio for NEO stock is 22.68x.

What is the estimated 10Y average EV/EBITDA ratio for NeoGenomics, Inc. (NEO)?

The estimated 10Y average EV/EBITDA ratio for NEO stock is 10.15x.

What is the estimated 15Y average EV/EBITDA ratio for NeoGenomics, Inc. (NEO)?

The estimated 15Y average EV/EBITDA ratio for NEO stock is 13.02x.

DATE	EV/EBITDA RATIO
2021-11-04	93.89x
2021-11-03	110.33x
2021-11-02	110.00x
2021-11-01	111.39x
2021-10-29	109.26x
2021-10-28	109.28x
2021-10-27	106.15x
2021-10-26	109.00x
2021-10-25	107.99x
2021-10-22	107.03x
2021-10-21	106.87x
2021-10-20	106.13x
2021-10-19	108.01x
2021-10-18	104.54x
2021-10-15	104.00x
2021-10-14	104.44x
2021-10-13	101.22x
2021-10-12	98.95x
2021-10-11	99.35x
2021-10-08	100.74x
2021-10-07	106.65x
2021-10-06	103.19x
2021-10-05	104.18x
2021-10-04	103.67x
2021-10-01	114.27x
2021-09-30	113.76x
2021-09-29	114.91x
2021-09-28	109.78x
2021-09-27	111.15x
2021-09-24	110.99x
2021-09-23	117.18x
2021-09-22	117.54x
2021-09-21	113.56x
2021-09-20	111.27x
2021-09-17	113.92x
2021-09-16	112.03x
2021-09-15	111.63x
2021-09-14	114.59x
2021-09-13	120.42x
2021-09-10	122.37x
2021-09-09	119.93x
2021-09-08	119.03x
2021-09-07	120.72x
2021-09-03	120.03x
2021-09-02	119.41x
2021-09-01	117.80x
2021-08-31	114.53x
2021-08-30	115.65x
2021-08-27	114.27x
2021-08-26	111.53x
2021-08-25	109.02x
2021-08-24	108.62x
2021-08-23	106.51x
2021-08-20	105.02x
2021-08-19	102.71x
2021-08-18	101.22x
2021-08-17	101.70x
2021-08-16	101.64x
2021-08-13	102.25x
2021-08-12	102.93x
2021-08-11	100.54x
2021-08-10	101.84x
2021-08-09	72.48x
2021-08-06	74.47x
2021-08-05	76.04x
2021-08-04	75.68x
2021-08-03	73.56x
2021-08-02	73.38x
2021-07-30	73.41x
2021-07-29	72.75x
2021-07-28	71.61x
2021-07-27	69.13x
2021-07-26	71.22x
2021-07-23	72.77x
2021-07-22	71.28x
2021-07-21	71.59x
2021-07-20	70.25x
2021-07-19	69.50x
2021-07-16	68.95x
2021-07-15	67.30x
2021-07-14	68.21x
2021-07-13	71.94x
2021-07-12	72.23x
2021-07-09	71.99x
2021-07-08	71.25x
2021-07-07	71.84x
2021-07-06	71.41x
2021-07-02	69.90x
2021-07-01	71.41x
2021-06-30	71.89x
2021-06-29	74.06x
2021-06-28	74.32x
2021-06-25	73.91x
2021-06-24	73.91x
2021-06-23	71.43x
2021-06-22	70.63x
2021-06-21	69.96x
2021-06-18	68.54x
2021-06-17	69.29x
2021-06-16	67.97x
2021-06-15	69.31x
2021-06-14	69.27x
2021-06-11	68.51x
2021-06-10	68.13x
2021-06-09	67.69x
2021-06-08	66.56x
2021-06-07	66.01x
2021-06-04	64.91x
2021-06-03	63.62x
2021-06-02	63.85x
2021-06-01	64.91x
2021-05-28	65.12x
2021-05-27	64.58x
2021-05-26	63.67x
2021-05-25	62.08x
2021-05-24	61.79x
2021-05-21	61.41x
2021-05-20	61.20x
2021-05-19	59.99x
2021-05-18	59.62x
2021-05-17	59.57x
2021-05-14	60.35x
2021-05-13	57.92x
2021-05-12	59.98x
2021-05-11	61.82x
2021-05-10	60.68x
2021-05-07	65.22x
2021-05-06	43.79x
2021-05-05	43.67x
2021-05-04	49.58x
2021-05-03	49.60x
2021-04-30	51.07x
2021-04-29	51.34x
2021-04-28	52.95x
2021-04-27	53.15x
2021-04-26	53.91x
2021-04-23	52.84x
2021-04-22	52.13x
2021-04-21	53.37x
2021-04-20	49.76x
2021-04-19	50.03x
2021-04-16	51.44x
2021-04-15	51.65x
2021-04-14	51.28x
2021-04-13	51.62x
2021-04-12	50.99x
2021-04-09	50.21x
2021-04-08	49.90x
2021-04-07	48.94x
2021-04-06	50.88x
2021-04-05	51.41x
2021-04-01	50.59x
2021-03-31	50.27x
2021-03-30	46.57x
2021-03-29	45.94x
2021-03-26	48.33x
2021-03-25	47.97x
2021-03-24	49.72x
2021-03-23	50.79x
2021-03-22	53.13x
2021-03-19	52.32x
2021-03-18	50.93x
2021-03-17	53.44x
2021-03-16	52.35x
2021-03-15	52.13x
2021-03-12	51.33x
2021-03-11	50.23x
2021-03-10	47.86x
2021-03-09	46.77x
2021-03-08	43.26x
2021-03-05	45.04x
2021-03-04	47.08x
2021-03-03	50.48x
2021-03-02	53.81x
2021-03-01	55.47x
2021-02-26	53.15x
2021-02-25	67.38x
2021-02-24	72.04x
2021-02-23	70.23x
2021-02-22	70.94x
2021-02-19	75.02x
2021-02-18	75.33x
2021-02-17	75.84x
2021-02-16	78.66x
2021-02-12	79.47x
2021-02-11	77.69x
2021-02-10	77.11x
2021-02-09	76.03x
2021-02-08	74.32x
2021-02-05	72.93x
2021-02-04	71.05x
2021-02-03	70.03x
2021-02-02	72.16x
2021-02-01	70.58x
2021-01-29	70.27x
2021-01-28	70.62x
2021-01-27	70.96x
2021-01-26	72.82x
2021-01-25	75.49x
2021-01-22	74.31x
2021-01-21	73.32x
2021-01-20	74.52x
2021-01-19	71.28x
2021-01-15	69.95x
2021-01-14	70.89x
2021-01-13	69.99x
2021-01-12	70.66x
2021-01-11	70.70x
2021-01-08	69.49x
2021-01-07	70.94x
2021-01-06	68.03x
2021-01-05	72.71x
2021-01-04	72.58x
2020-12-31	71.37x
2020-12-30	71.81x
2020-12-29	69.70x
2020-12-28	73.26x
2020-12-24	73.46x
2020-12-23	73.48x
2020-12-22	74.90x
2020-12-21	71.65x
2020-12-18	71.08x
2020-12-17	71.01x
2020-12-16	69.15x
2020-12-15	68.64x
2020-12-14	68.90x
2020-12-11	67.23x
2020-12-10	66.49x
2020-12-09	65.58x
2020-12-08	64.17x
2020-12-07	65.16x
2020-12-04	63.55x
2020-12-03	63.42x
2020-12-02	62.54x
2020-12-01	62.32x
2020-11-30	62.98x
2020-11-27	62.68x
2020-11-25	60.47x
2020-11-24	59.66x
2020-11-23	60.41x
2020-11-20	59.21x
2020-11-19	56.47x
2020-11-18	56.11x
2020-11-17	59.17x
2020-11-16	56.93x
2020-11-13	55.18x
2020-11-12	54.16x
2020-11-11	57.79x
2020-11-10	56.70x
2020-11-09	53.77x
2020-11-06	53.69x
2020-11-05	53.91x
2020-11-04	53.53x
2020-11-03	52.51x
2020-11-02	50.42x
2020-10-30	51.78x
2020-10-29	59.66x
2020-10-28	57.29x
2020-10-27	59.50x
2020-10-26	60.60x

DATE

EV/EBITDA RATIO

2021-11-04

93.89x

2021-11-03

110.33x

2021-11-02

110.00x

2021-11-01

111.39x

2021-10-29

109.26x

2021-10-28

109.28x

2021-10-27

106.15x

2021-10-26

109.00x

2021-10-25

107.99x

2021-10-22

107.03x

2021-10-21

106.87x

2021-10-20

106.13x

2021-10-19

108.01x

2021-10-18

104.54x

2021-10-15

104.00x

2021-10-14

104.44x

2021-10-13

101.22x

2021-10-12

98.95x

2021-10-11

99.35x

2021-10-08

100.74x

2021-10-07

106.65x

2021-10-06

103.19x

2021-10-05

104.18x

2021-10-04

103.67x

2021-10-01

114.27x

2021-09-30

113.76x

2021-09-29

114.91x

2021-09-28

109.78x

2021-09-27

111.15x

2021-09-24

110.99x

2021-09-23

117.18x

2021-09-22

117.54x

2021-09-21

113.56x

2021-09-20

111.27x

2021-09-17

113.92x

2021-09-16

112.03x

2021-09-15

111.63x

2021-09-14

114.59x

2021-09-13

120.42x

2021-09-10

122.37x

2021-09-09

119.93x

2021-09-08

119.03x

2021-09-07

120.72x

2021-09-03

120.03x

2021-09-02

119.41x

2021-09-01

117.80x

2021-08-31

114.53x

2021-08-30

115.65x

2021-08-27

114.27x

2021-08-26

111.53x

2021-08-25

109.02x

2021-08-24

108.62x

2021-08-23

106.51x

2021-08-20

105.02x

2021-08-19

102.71x

2021-08-18

101.22x

2021-08-17

101.70x

2021-08-16

101.64x

2021-08-13

102.25x

2021-08-12

102.93x

2021-08-11

100.54x

2021-08-10

101.84x

2021-08-09

72.48x

2021-08-06

74.47x

2021-08-05

76.04x

2021-08-04

75.68x

2021-08-03

73.56x

2021-08-02

73.38x

2021-07-30

73.41x

2021-07-29

72.75x

2021-07-28

71.61x

2021-07-27

69.13x

2021-07-26

71.22x

2021-07-23

72.77x

2021-07-22

71.28x

2021-07-21

71.59x

2021-07-20

70.25x

2021-07-19

69.50x

2021-07-16

68.95x

2021-07-15

67.30x

2021-07-14

68.21x

2021-07-13

71.94x

2021-07-12

72.23x

2021-07-09

71.99x

2021-07-08

71.25x

2021-07-07

71.84x

2021-07-06

71.41x

2021-07-02

69.90x

2021-07-01

71.41x

2021-06-30

71.89x

2021-06-29

74.06x

2021-06-28

74.32x

2021-06-25

73.91x

2021-06-24

73.91x

2021-06-23

71.43x

2021-06-22

70.63x

2021-06-21

69.96x

2021-06-18

68.54x

2021-06-17

69.29x

2021-06-16

67.97x

2021-06-15

69.31x

2021-06-14

69.27x

2021-06-11

68.51x

2021-06-10

68.13x

2021-06-09

67.69x

2021-06-08

66.56x

2021-06-07

66.01x

2021-06-04

64.91x

2021-06-03

63.62x

2021-06-02

63.85x

2021-06-01

64.91x

2021-05-28

65.12x

2021-05-27

64.58x

2021-05-26

63.67x

2021-05-25

62.08x

2021-05-24

61.79x

2021-05-21

61.41x

2021-05-20

61.20x

2021-05-19

59.99x

2021-05-18

59.62x

2021-05-17

59.57x

2021-05-14

60.35x

2021-05-13

57.92x

2021-05-12

59.98x

2021-05-11

61.82x

2021-05-10

60.68x

2021-05-07

65.22x

2021-05-06

43.79x

2021-05-05

43.67x

2021-05-04

49.58x

2021-05-03

49.60x

2021-04-30

51.07x

2021-04-29

51.34x

2021-04-28

52.95x

2021-04-27

53.15x

2021-04-26

53.91x

2021-04-23

52.84x

2021-04-22

52.13x

2021-04-21

53.37x

2021-04-20

49.76x

2021-04-19

50.03x

2021-04-16

51.44x

2021-04-15

51.65x

2021-04-14

51.28x

2021-04-13

51.62x

2021-04-12

50.99x

2021-04-09

50.21x

2021-04-08

49.90x

2021-04-07

48.94x

2021-04-06

50.88x

2021-04-05

51.41x

2021-04-01

50.59x

2021-03-31

50.27x

2021-03-30

46.57x

2021-03-29

45.94x

2021-03-26

48.33x

2021-03-25

47.97x

2021-03-24

49.72x

2021-03-23

50.79x

2021-03-22

53.13x

2021-03-19

52.32x

2021-03-18

50.93x

2021-03-17

53.44x

2021-03-16

52.35x

2021-03-15

52.13x

2021-03-12

51.33x

2021-03-11

50.23x

2021-03-10

47.86x

2021-03-09

46.77x

2021-03-08

43.26x

2021-03-05

45.04x

2021-03-04

47.08x

2021-03-03

50.48x

2021-03-02

53.81x

2021-03-01

55.47x

2021-02-26

53.15x

2021-02-25

67.38x

2021-02-24

72.04x

2021-02-23

70.23x

2021-02-22

70.94x

2021-02-19

75.02x

2021-02-18

75.33x

2021-02-17

75.84x

2021-02-16

78.66x

2021-02-12

79.47x

2021-02-11

77.69x

2021-02-10

77.11x

2021-02-09

76.03x

2021-02-08

74.32x

2021-02-05

72.93x

2021-02-04

71.05x

2021-02-03

70.03x

2021-02-02

72.16x

2021-02-01

70.58x

2021-01-29

70.27x

2021-01-28

70.62x

2021-01-27

70.96x

2021-01-26

72.82x

2021-01-25

75.49x

2021-01-22

74.31x

2021-01-21

73.32x

2021-01-20

74.52x

2021-01-19

71.28x

2021-01-15

69.95x

2021-01-14

70.89x

2021-01-13

69.99x

2021-01-12

70.66x

2021-01-11

70.70x

2021-01-08

69.49x

2021-01-07

70.94x

2021-01-06

68.03x

2021-01-05

72.71x

2021-01-04

72.58x

2020-12-31

71.37x

2020-12-30

71.81x

2020-12-29

69.70x

2020-12-28

73.26x

2020-12-24

73.46x

2020-12-23

73.48x

2020-12-22

74.90x

2020-12-21

71.65x

2020-12-18

71.08x

2020-12-17

71.01x

2020-12-16

69.15x

2020-12-15

68.64x

2020-12-14

68.90x

2020-12-11

67.23x

2020-12-10

66.49x

2020-12-09

65.58x

2020-12-08

64.17x

2020-12-07

65.16x

2020-12-04

63.55x

2020-12-03

63.42x

2020-12-02

62.54x

2020-12-01

62.32x

2020-11-30

62.98x

2020-11-27

62.68x

2020-11-25

60.47x

2020-11-24

59.66x

2020-11-23

60.41x

2020-11-20

59.21x

2020-11-19

56.47x

2020-11-18

56.11x

2020-11-17

59.17x

2020-11-16

56.93x

2020-11-13

55.18x

2020-11-12

54.16x

2020-11-11

57.79x

2020-11-10

56.70x

2020-11-09

53.77x

2020-11-06

53.69x

2020-11-05

53.91x

2020-11-04

53.53x

2020-11-03

52.51x

2020-11-02

50.42x

2020-10-30

51.78x

2020-10-29

59.66x

2020-10-28

57.29x

2020-10-27

59.50x

2020-10-26

60.60x

EV/EBITDA Ratio: N/A

NEO EV/EBITDA Ratio Chart

NEO Average EV/EBITDA Ratio Chart

NEO EV/EBITDA Ratio Metrics

NEO Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

EV/EBITDA Ratio FAQ

NEO EV/EBITDA Ratio History

Related Metrics